MP
PEPLW

Mangrove Partners’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Mangrove Partners’s Portfolio PEPLW Stock Details PEPLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,129
Closed -$154K – 321
2022
Q4 		$154K Hold
15,129
– – 0.01% 310
2022
Q3 		$151K Buy
+15,129
New +$2.19K 0.01% 334

Other funds holding PEPLW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Mangrove Partners's PEPLW Position: Q1 2023 in Review

Mangrove Partners sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2023, closing a stake of 15,129 shares — an estimated $154K sold.

Mangrove Partners first reported a position in PEPLW in Q3 2022 and held it in 2 quarters. The position peaked at $154K in Q4 2022. 23 funds tracked by Wall St. Rank hold PEPLW as of Q1 2023.

  • Mangrove Partners reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2023 after selling out during the quarter.
  • Mangrove Partners sold 15,129 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2023, an estimated $154K.
  • Mangrove Partners first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q3 2022 and held it in 2 quarters.
  • Mangrove Partners's PepperLime Health Acquisition Corporation Warrrant position peaked at $154K in Q4 2022.
  • 23 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2023.

Based on Mangrove Partners's 13F filing for Q1 2023, filed 15 May 2023.